Wedbush Has Lowered Expectations for Healthpeak Properties (NYSE:DOC) Stock Price

Healthpeak Properties (NYSE:DOC) had its target price dropped by equities research analysts at Wedbush from $24.00 to $22.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has an “outperform” rating on the real estate investment trust’s stock. Wedbush’s target price suggests a potential upside of 24.24% from the company’s current price.

Several other analysts have also issued reports on DOC. Robert W. Baird dropped their price target on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Tuesday, February 11th. StockNews.com downgraded Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Wednesday, April 23rd. Morgan Stanley raised shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price for the company in a research report on Wednesday, January 15th. Finally, Scotiabank cut their price objective on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $23.91.

Healthpeak Properties Stock Performance

NYSE:DOC opened at $17.71 on Monday. Healthpeak Properties has a 52-week low of $17.33 and a 52-week high of $23.26. The company has a market cap of $12.39 billion, a price-to-earnings ratio of 50.85, a PEG ratio of 2.17 and a beta of 1.02. The firm’s 50-day moving average is $19.57 and its 200-day moving average is $20.56. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.46. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The company had revenue of $702.89 million during the quarter, compared to analysts’ expectations of $690.76 million. Equities research analysts anticipate that Healthpeak Properties will post 1.86 earnings per share for the current year.

Hedge Funds Weigh In On Healthpeak Properties

Hedge funds have recently made changes to their positions in the stock. Barclays PLC purchased a new position in Healthpeak Properties during the third quarter valued at approximately $35,078,000. Diamant Asset Management Inc. bought a new position in Healthpeak Properties in the 3rd quarter worth about $564,000. World Investment Advisors LLC purchased a new stake in shares of Healthpeak Properties in the 3rd quarter valued at about $291,000. Sfmg LLC purchased a new position in shares of Healthpeak Properties during the third quarter worth about $2,245,000. Finally, Wilmington Savings Fund Society FSB purchased a new stake in Healthpeak Properties in the third quarter valued at approximately $125,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.